Security key
745848101
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 138,973
- Total 13F value
- $186,247
- Share change
- +99,983
- SEC-reported price per share
- $1.30
- Number of holders
- 9
- Value change
- +$135,556
- Number of buys
- 6
- Number of sells
- 2
- Shares outstanding
- 41,001,538
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
9
Top holders
9
LUNG full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Pulmonx Corp SEC filings
Pulmonx Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 745848101
Recent filing periods:
Ownership snapshot
Top reported holders of LUNG - Pulmonx Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRIMECAP MANAGEMENT CO/CA/
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
05 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 12%
13D/G row: PRIMECAP MANAGEMENT CO/CA/
Showing 1-6 of 15 holder rows.
Quick read
PRIMECAP MANAGEMENT CO/CA/ leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRIMECAP MANAGEMENT CO/CA/'s linked filing trail.
Comparable ownership
Top 5
PRIMECAP MANAGEMENT CO/CA/
12%
MORGAN STANLEY
8.5%
BlackRock, Inc.
6.8%
Soleus Capital Master Fund, L.P.
6.5%
FMR LLC
0.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13D/G
13F
Company
|
12%
|
$8,029,839
4,956,691 shares
|
-$742,073 | 30 Sep 2025 |
| MORGAN STANLEY |
13D/G
13F
Company
|
8.5%
|
$17,530,110
3,390,737 shares
|
+$2,200,052 | 31 Mar 2025 |
| BlackRock, Inc. |
13D/G
13F
Company
|
6.8%
|
$13,933,140
2,694,998 shares
|
$0 | 31 Mar 2025 |
| Soleus Capital Master Fund, L.P. |
13D/G
|
6.5%
|
$4,344,113
2,665,100 shares
|
$0 | 06 Mar 2026 |
| FMR LLC |
13D/G
13F
Company
|
0.2%
|
$114,736
70,825 shares
|
-$3,416,852 | 31 Oct 2025 |
| Geoffrey Beran Rose |
3/4/5
CHIEF COMMERCIAL OFFICER
|
1.1%
|
$704,874
457,711 shares
|
-$43,807 | 01 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
138,973
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
110
Q2 2026 holders
9
Holder diff
-101
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend